Also, in this model, inhibition of 11β-HSD1 delayed tumor growth and, moreover, sensitized tumor cells to anti–PD-1 treatment, suggesting that GC inhibition may increase the effectiveness of immune checkpoint blockade in the clinic. Here, PDCD1 is linked to neoplasm.